CTRI/2023/08/056433
尚未招募
4 期
A Prospective Randomized, Placebo-Controlled, Phase IV Study to Evaluate the Efficacy of CelWel in Patients with Postviral Fatigue Syndrome - NI
Carmel Research Consultancy Private Limited0 个研究点目标入组 0 人待定
概览
- 阶段
- 4 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Health Condition 1: G933- Postviral fatigue syndrome
- 发起方
- Carmel Research Consultancy Private Limited
- 状态
- 尚未招募
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\.Male and female subjects over 18 years of age
- •2\.Willingness to follow the protocol requirements
- •as evidenced by written, informed consent.
- •3\.Mentally, physically and legally eligible to
- •give informed consent
- •4\.Willingness to complete study questionnaires.
- •5\.Able to use a smartphone and an mobile
- •application for delivering feedback every week
- •on symptoms
排除标准
- •1\.Patients with pre\-existing or other severe
- •systemic diseases that necessitate long\-term
- •medication.
- •2\.Any vascular or systemic disorder which could
- •affect any of the efficacy assessments.
- •3\.Subjects received other medication (anti\-viral)
- •within 36 hours before entry into the study.
- •4\.Evidence of significant uncontrolled co\-morbid
- •disease, which in the investigators opinion, would
- •jeopardize patient participation.
结局指标
主要结局
未指定
相似试验
进行中（未招募）
1 期
OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)EUCTR2018-000075-33-GBOmeros Corporation450
进行中（未招募）
1 期
OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)EUCTR2018-000075-33-SKOmeros Corporation450
进行中（未招募）
1 期
Benralizumab tested in patients with chronic prurigo.EUCTR2021-002818-13-DECharité-Universitätsmedizin Berlin48
进行中（未招募）
1 期
A study of androgen deprivation therapy (ADT) plus apalutamide (with or without abiraterone acetate with prednisone/prednisolone [AAP]) in patients with prostate cancerHigh-risk localized or locally advanced prostate cancerMedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2018-001746-34-FRJanssen-Cilag International NV1,500
进行中（未招募）
1 期
A study to see the Safety and Efficacy of Abaloparatide- SC for the Treatment of Men with OsteoporosisEUCTR2017-004220-30-ITRADIUS HEALTH, INC225